Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Statu

Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status is a phase 2, interventional study registered as NCT06356714 by Sun Jing, with a registry enrolment figure of 22 participants, started 2025-03-15 and due to reach its primary completion in 2026-09-24. Interventions recorded: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens. Conditions listed: Colorectal Cancer; Colorectal Neoplasms. Primary outcome: Progression-free survival(PFS). Colorectal eligibility wording from the registry: "Colorectal adenocarcinoma confirmed by pathologic histology and/or cytology and imaging;". Sites: China. No results are recorded here; the registry entry is the source.